Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel multi-antigen targeted CAR-NK cell for the treatment of B cell...

Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA

Novel multi-antigen targeted CAR-NK cell for the treatment of B cell malignancies ( Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA )

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise

Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )

Evaluating emerging mutations in patients with acute myeloid leukaemia who...

Dr Catherine Smith - University of California San Francisco, San Francisco, USA

Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial ( Dr Catherine Smith - University of California San Francisco, San Francisco, USA )

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD...

Dr James Foran - Mayo Clinic Florida, Jacksonville, USA

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients ( Dr James Foran - Mayo Clinic Florida, Jacksonville, USA )

Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma

Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China

Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )

Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin...

Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA

Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients ( Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA )

CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained...

Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China

CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )

Dual-targeted antibody mosunetuzumab elicits durable responses in poor...

Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA

Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients ( Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA )

Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have...

Prof Deepu Madduri - Mount Sinai, New York, USA

Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have high response rate ( Prof Deepu Madduri - Mount Sinai, New York, USA )

Cellular immunotherapy for B cell cancers shows promise

Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA

Cellular immunotherapy for B cell cancers shows promise ( Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA )

The importance of SIOG's collaboration with ACCC

Dr Stuart Lichtman - Memorial-Sloan-Kettering Cancer Center, New York, USA

The importance of SIOG's collaboration with ACCC ( Dr Stuart Lichtman - Memorial-Sloan-Kettering Cancer Center, New York, USA )

Providing practical tips for completing geriatric assessments

Dr Melissa Loh - Rochester Medical Center, Rochester, USA

Providing practical tips for completing geriatric assessments ( Dr Melissa Loh - Rochester Medical Center, Rochester, USA )

More from ecancer